Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M-C Hsu

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
Advances in Contraceptive Delivery Systems : CDS|January 1, 1992
Intrauterine devices Wang S.S Cu 380 as compared to ML Cu 375, Nova T, T Cu 300, 7 Cu 200, Lippes Loop and Ohta Ring: clinical / physiopathological parametersF N Wang, M C Hsu, C M Cheng, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 15, 1993
Inhibition of type 1 human immunodeficiency virus replication by a tat antagonist to which the virus remains sensitive after prolonged exposure in vitroM C Hsu, U Dhingra, J V Earley, et al.
Oncogene|February 5, 2013
Syntaxin 6-mediated Golgi translocation plays an important role in nuclear functions of EGFR through microtubule-dependent traffickingY Du, J Shen, J L Hsu, et al.
The British Journal of Dermatology|October 14, 2014
Long-term efficacy and safety of ustekinumab, with and without dosing adjustment, in patients with moderate-to-severe psoriasis: results from the PHOENIX 2 study through 5 years of follow-upR G Langley, M Lebwohl, G G Krueger, et al.
Journal of Natural Products|November 23, 2000
Cytotoxic constituents of Polyalthia longifolia var. pendulaC Y Chen, F R Chang, Y C Shih, et al.
The British Journal of Dermatology|March 17, 2020
Ustekinumab for the treatment of moderate-to-severe plaque psoriasis in paediatric patients (≥ 6 to < 12 years of age): efficacy, safety, pharmacokinetic and biomarker results from the open-label CADMUS Jr studyS Philipp, A Menter, A F Nikkels, et al.
The British Journal of Dermatology|January 11, 2013
Long-term safety of ustekinumab in patients with moderate-to-severe psoriasis: final results from 5 years of follow-upK A Papp, C E M Griffiths, K Gordon, et al.
European Journal of Clinical Investigation|October 8, 2008
Apoptotic effect of Helicobacter pylori on oesophageal squamous-cell carcinoma cells in vitroI-C Wu, M-T Wu, Y-K Chen, et al.
The British Journal of Dermatology|June 11, 2017
Extension of ustekinumab maintenance dosing interval in moderate-to-severe psoriasis: results of a phase IIIb, randomized, double-blinded, active-controlled, multicentre study (PSTELLAR)A Blauvelt, L K Ferris, P S Yamauchi, et al.
European Journal of Neurology|September 20, 2017
Pre-stroke physical activity is associated with fewer post-stroke complications, lower mortality and a better long-term outcomeC-P Wen, C-H Liu, J-S Jeng, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Advances in Contraceptive Delivery Systems : CDS|January 1, 1992
Intrauterine devices Wang S.S Cu 380 as compared to ML Cu 375, Nova T, T Cu 300, 7 Cu 200, Lippes Loop and Ohta Ring: clinical / physiopathological parametersF N Wang, M C Hsu, C M Cheng, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 15, 1993
Inhibition of type 1 human immunodeficiency virus replication by a tat antagonist to which the virus remains sensitive after prolonged exposure in vitroM C Hsu, U Dhingra, J V Earley, et al.
Oncogene|February 5, 2013
Syntaxin 6-mediated Golgi translocation plays an important role in nuclear functions of EGFR through microtubule-dependent traffickingY Du, J Shen, J L Hsu, et al.
The British Journal of Dermatology|October 14, 2014
Long-term efficacy and safety of ustekinumab, with and without dosing adjustment, in patients with moderate-to-severe psoriasis: results from the PHOENIX 2 study through 5 years of follow-upR G Langley, M Lebwohl, G G Krueger, et al.
Journal of Natural Products|November 23, 2000
Cytotoxic constituents of Polyalthia longifolia var. pendulaC Y Chen, F R Chang, Y C Shih, et al.
The British Journal of Dermatology|March 17, 2020
Ustekinumab for the treatment of moderate-to-severe plaque psoriasis in paediatric patients (≥ 6 to < 12 years of age): efficacy, safety, pharmacokinetic and biomarker results from the open-label CADMUS Jr studyS Philipp, A Menter, A F Nikkels, et al.
The British Journal of Dermatology|January 11, 2013
Long-term safety of ustekinumab in patients with moderate-to-severe psoriasis: final results from 5 years of follow-upK A Papp, C E M Griffiths, K Gordon, et al.
European Journal of Clinical Investigation|October 8, 2008
Apoptotic effect of Helicobacter pylori on oesophageal squamous-cell carcinoma cells in vitroI-C Wu, M-T Wu, Y-K Chen, et al.
The British Journal of Dermatology|June 11, 2017
Extension of ustekinumab maintenance dosing interval in moderate-to-severe psoriasis: results of a phase IIIb, randomized, double-blinded, active-controlled, multicentre study (PSTELLAR)A Blauvelt, L K Ferris, P S Yamauchi, et al.
European Journal of Neurology|September 20, 2017
Pre-stroke physical activity is associated with fewer post-stroke complications, lower mortality and a better long-term outcomeC-P Wen, C-H Liu, J-S Jeng, et al.
Pageof 7